Semaglutide

What Is Semaglutide?

• Semaglutide is a medication used to manage type 2 diabetes and assist with weight loss.
• Belongs to a class of drugs called GLP-1 receptor agonists (glucagon-like peptide-1 agonists).
• Approved for managing blood sugar (brand names: Ozempic, Rybelsus) and chronic weight management (brand name: Wegovy).

What Are GLP-1 Receptor Agonists?

• Mimic the action of GLP-1, a hormone naturally produced in the gut.
• GLP-1 regulates blood sugar and appetite by:
  • Stimulating insulin secretion when blood sugar levels are high.
  • Slowing down stomach emptying to increase feelings of fullness.
  • Reducing appetite and food intake.
• Used to treat type 2 diabetes and obesity.

How Does Semaglutide Work?

• Activates GLP-1 receptors in the pancreas, stomach, and brain.
• Enhances insulin release and reduces glucagon secretion, lowering blood sugar levels.
• Slows gastric emptying, leading to prolonged satiety.
• Targets appetite centers in the brain, reducing calorie intake.

Uses of Semaglutide

• Type 2 Diabetes Management: Improves blood sugar control when combined with diet and exercise.
• Weight Management: Approved for adults with:
  • BMI ≥30 (obesity).
  • BMI ≥27 (overweight) with at least one weight-related condition (e.g., hypertension, high cholesterol).
• Cardiovascular Risk Reduction: Lowers the risk of major cardiovascular events in patients with type 2 diabetes and heart disease.

Benefits of Semaglutide and GLP-1 Agonists

• Effective in lowering blood sugar levels.
• Promotes significant weight loss.
• Reduces the risk of cardiovascular events like heart attack and stroke.
• Improves overall metabolic health by lowering cholesterol and blood pressure.
• Enhances patient adherence due to once-weekly dosing for injections.

Types of Semaglutide Formulations

• Ozempic (Injection):
  • Weekly injection for type 2 diabetes.
  • Administered subcutaneously in the abdomen, thigh, or upper arm.
• Rybelsus (Oral):
  • Daily oral tablet for type 2 diabetes.
  • Taken on an empty stomach with water.
• Wegovy (Injection):
  • Weekly injection for chronic weight management.

Dosing Guidelines

• For Type 2 Diabetes (Ozempic, Rybelsus):
  • Starting dose: 0.25 mg once weekly (Ozempic) or 3 mg daily (Rybelsus).
  • Maintenance dose: 1 mg once weekly or 7-14 mg daily for Rybelsus.
• For Weight Management (Wegovy):
  • Starting dose: 0.25 mg once weekly.
  • Gradually increased to 2.4 mg weekly over several weeks to minimize side effects.

Possible Side Effects

Common Side Effects

• Nausea and vomiting.
• Diarrhea or constipation.
• Abdominal discomfort or bloating.
• Decreased appetite.

Less Common but Serious Side Effects

• Pancreatitis: Symptoms include severe abdominal pain, nausea, and vomiting.
• Gallbladder Issues: Increased risk of gallstones or inflammation.
• Kidney Damage: Rare but possible, especially with dehydration.
• Thyroid Tumors: Increased risk in animal studies; relevance to humans is unclear.

Drug Interactions

• Insulin or Sulfonylureas: Risk of low blood sugar (hypoglycemia).
• Oral Medications: Delayed gastric emptying can affect the absorption of some drugs.
• Other GLP-1 Agonists: Avoid concurrent use to prevent side effects.

Contraindications

• Personal or family history of medullary thyroid carcinoma (MTC).
• History of multiple endocrine neoplasia syndrome type 2 (MEN 2).
• Severe gastrointestinal conditions like gastroparesis.
• Allergy to semaglutide or any of its components.

Monitoring and Follow-Up

• Blood Sugar Levels: Regular checks to ensure effective diabetes control.
• Weight Progress: Monitor weight loss over time for effectiveness.
• Kidney Function: Assess in patients with pre-existing kidney issues.
• Gallbladder Health: Evaluate for signs of gallstones or inflammation.

Counseling Points for Patients

• Take semaglutide exactly as prescribed, with gradual dose increases to minimize nausea.
• Use a healthy diet and exercise routine to enhance medication effects.
• Report symptoms like severe abdominal pain, persistent vomiting, or yellowing of the skin.
• Store injection pens in the refrigerator and protect from heat or light.
• Avoid sharing injection pens, even with clean needles.

FAQs About Semaglutide and GLP-1 Agonists

Q1: How long does it take for semaglutide to work?

• Improvements in blood sugar levels may be seen within 1-2 weeks. Weight loss effects become noticeable within 8-12 weeks.

Q2: Can semaglutide cause low blood sugar?

• Alone, semaglutide rarely causes low blood sugar, but the risk increases when combined with insulin or sulfonylureas.

Q3: Is semaglutide safe during pregnancy?

• Not recommended during pregnancy; consult your doctor for alternative treatments.

Q4: Can semaglutide be used for type 1 diabetes?

• No, it is not approved for use in type 1 diabetes.

Q5: What should I do if I miss a dose?

• Take the missed dose as soon as possible, unless it is less than 2 days until the next scheduled dose.

Q6: Are GLP-1 agonists effective for everyone?

• They are effective for many patients, but individual results may vary.

Q7: Can I use semaglutide for weight loss if I don’t have diabetes?

• Yes, Wegovy is specifically approved for weight loss in non-diabetic individuals with obesity or overweight.

---

---